CCNE1 and hepatocellular carcinoma: ExosomeRNP targeting PUMA ameliorated acute liver injury. ExosomeRNP targeting CcnE1 ameliorated chronic liver fibrosis. ExosomeRNP targeting KAT5 administered by tail vein injections ameliorated orthotopic hepatocellular carcinoma (HCC).